Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2022 - 11 - 03 save search
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
Published: 2022-11-03 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 0.0%
H: 0.6%
C: -2.41%
report business update therapeutics financial results
XORTX Presents New Proof of Concept Data at American Society of Nephrology
Published: 2022-11-03 (Crawled : 13:47) - xortx.com
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 4.88%
H: 4.65%
C: -6.87%
Nektar Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 00:00) - biospace.com/
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -0.84%
therapeutics financial results
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 22:00) - globenewswire.com
CDTX | $0.7201 -0.29% -0.29% 270K
|
Health Technology
|
| O: 1.03%
H: 2.68%
C: -3.25%
therapeutics financial update results
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2022
Published: 2022-11-03 (Crawled : 21:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 5.74%
H: 2.66%
C: -1.33%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: -4.88%
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -3.51%
financial update
Poseida Therapeutics Announces Oral Presentation Highlighting P-FVIII-101 Gene Therapy at the 64th ASH Annual Meeting & Exposition
Published: 2022-11-03 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: -0.52%
H: 7.63%
C: 6.84%
fviii-101 meeting therapeutics presentation therapy
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-03 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.02%
H: 2.67%
C: 0.18%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.83%
H: 1.33%
C: -0.51%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.43%
H: 0.41%
C: 0.25%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.4%
H: 2.75%
C: 1.52%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.72%
H: 1.29%
C: 1.04%
covid-19 treatment research global report impact health market
XORTX Announces Participation at Upcoming Investor Conferences
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: -1.27%
H: 15.38%
C: 5.13%
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - biospace.com/
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
|
| O: -2.18%
H: 8.91%
C: 8.17%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
meeting therapeutics presentation
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.36%
H: 2.68%
C: -0.18%
otl-201 therapeutics presentation study
CRISPR Therapeutics Announces Poster Presentation on CTX110® at the American Society of Hematology (ASH) 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
CRSP M | $56.14 1.04% 1.03% 1.7M
|
Health Technology
|
| O: -0.53%
H: 0.13%
C: -2.11%
ctx110 crispr meeting therapeutics presentation
TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
TCRX 1 d | $6.9 2.22% 2.17% 250K
|
Professional, Scientific, and T...
|
| O: 3.01%
H: 5.47%
C: 5.47%
meeting therapeutics presentation
Chinook Therapeutics Presents Updated Data from Atrasentan Phase 2 AFFINITY IgA Nephropathy (IgAN) Patient Cohort, Preclinical Atrasentan Research and Ongoing Clinical Trials at the American Society of Nephrology (ASN) Kidney Week 2022
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: -1.53%
H: 3.8%
C: 1.69%
ongoing nephropathy trials research preclinical kidney week therapeutics igan
4D Molecular Therapeutics Announces Interim Clinical Data from Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease at NACFC 2022
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
FDMT | News | $24.71 -2.33% -2.39% 420K
|
Health Technology
|
| O: -1.58%
H: 19.95%
C: 9.48%
fibrosis lung disease trial therapeutics molecular cystic fibrosis phase 1
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Third-Quarter 2022 Financial Results and Discuss Recent Corporate Highlights
Published: 2022-11-03 (Crawled : 13:20) - biospace.com/
ALDX | News | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: -0.92%
H: 3.92%
C: 2.99%
conference report therapeutics financial results
Beam Therapeutics to Present New Preclinical Data Highlighting Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant at the 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
BEAM | $24.33 0.08% 0.08% 1.7M
|
Health Technology
|
| O: -2.27%
H: 6.76%
C: 3.29%
disease preclinical meeting therapeutics
Allogene Therapeutics Announces Poster Presentation of Its Phase 1 UNIVERSAL Trial in Multiple Myeloma at the 64th Annual Meeting of the American Society of Hematology
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: -7.47%
H: 4.2%
C: 1.17%
meeting universal trial therapeutics presentation phase 1
Harpoon Therapeutics to Present Interim Results from Phase 1 Clinical Trial of T Cell Engager HPN217 at the 64th ASH Annual Meeting and Exposition
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 7.18%
H: 1.33%
C: -3.48%
hpn217 meeting trial therapeutics results phase 1
Regulus Therapeutics Announces Timing for Third Quarter 2022 Financial Results Webcast and Conference Call
Published: 2022-11-03 (Crawled : 13:00) - biospace.com/
RGLS | $2.22 -5.13% -5.41% 200K
|
Health Technology
|
| O: -2.07%
H: 1.41%
C: -3.52%
conference therapeutics financial
Lineage Cell Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on November 10, 2022
Published: 2022-11-03 (Crawled : 13:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.0%
H: 5.38%
C: 1.54%
report therapeutics financial update results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.